The Melanoma Letter Winter 2012, Vol. 30, No. 4

New research out of Europe may tip the balance in favor of melanoma screening. In this issue of The Melanoma Letter, Dr. Katalinic and colleagues describe a nationwide one-year melanoma screening program conducted in the German state of Schleswig-Holstein from July 2003 to June 2004. This public health campaign, predicated on the intuitive benefits of melanoma screening, was not formally designed to test its impact on mortality. Nonetheless, given the extent of the campaign and its finding that melanoma mortality declined after initiation of screening by as much as 50 percent in Schleswig-Holstein (while remaining unchanged in three adjacent, unscreened German states or in Germany as a whole), the German experience may well change the landscape of melanoma screening dramatically worldwide.